Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DT53BH
|
|||
| Drug Name |
NPT520-34
|
|||
| Drug Type |
Small molecule
|
|||
| Indication | Amyotrophic lateral sclerosis [ICD-11: 8B60.0; ICD-9: 335.2] | Phase 1 | [1] | |
| Company |
Neuropore Therapies San Diego, CA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03954600) A Phase 1, Randomized, Double-Blind, Single and Multiple Ascending Dose Trial of the Safety, Tolerability and Pharmacokinetics of NPT520-34 in Healthy Subjects. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.